PEP-Therapy
Bruno Giroux is an Independent consultant with more than 35 years of experience in the field of oncology. Previously Director of clinical oncology R&D at Servier International Research Institute, then Medical Director of the Onco-Hematology Business Unit at Roche, Scientific and Medical Manager at Bioalliance, Associate Director Medical Affairs at CAC, a CRO in oncology, and Clinical Development Oncology Manager at Rock.
This person is not in the org chart
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.